Raw material GMP system in inactive status

Published: 2010-06-16 06:58:00

Updated: 2010-06-16 06:58:00

The current GMP (good manufacturing practice) regulation for raw materials is yet to be activated under the current drug master file (DMF) system, according to the Korea Food and Drug Administration.

Under such circumstances, the drug agency is considering expanding the scope of the DMP system...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK